Digital Biomarkers Market Size, Share, Trends, and Growth Outlook

Digital Biomarkers Market is estimated to increase at a growth rate of 28.2% CAGR over the forecast period from 2024 to 2030.

The Digital Biomarkers Market study analyzes and forecasts the market size across 6 regions and 24 countries for diverse segments including By Type (Wearable, Mobile based Applications, Sensors, Others), By Clinical Practice (Diagnostic Digital Biomarkers, Monitoring Digital Biomarkers, Predictive and Prognostic Digital Biomarkers, Others), By Therapeutic Area (Cardiovascular and metabolic disorders (CVMD), Respiratory disorders, Psychiatric disorders, Sleep & Movement Disease, Neurological disorders, Musculoskeletal disorders, Others), By End-user (Healthcare companies, Healthcare Providers, Payers, Others).

 

An Introduction to Digital Biomarkers Market in 2024

The digital biomarkers market in 2024 serves the demand for objective and quantifiable measures of health and disease derived from digital health technologies, wearable devices, biosensors, and mobile apps for remote monitoring, disease management, and clinical research applications. Digital biomarkers encompass physiological, behavioral, and environmental data collected from digital devices and sensors, providing insights into health status, disease progression, treatment response, and patient outcomes in real time. Market dynamics are driven by factors such as the increasing adoption of digital health solutions, the growing demand for personalized medicine and precision health analytics, and advancements in sensor technology and data analytics for biomarker discovery and validation. Collaboration between digital health companies, biomedical researchers, and healthcare providers drives innovation and market expansion in digital biomarkers, supporting improved healthcare delivery and patient-centered outcomes across diverse disease areas and therapeutic areas.

 

Digital Biomarkers Market Trend: Integration of Wearable Devices and Remote Monitoring

A significant trend in the Digital Biomarkers market is the integration of wearable devices and remote monitoring technologies for data collection and analysis. Wearable devices such as smartwatches, fitness trackers, and medical-grade sensors enable continuous monitoring of physiological parameters, behaviors, and symptoms in real time. This trend is driven by advancements in sensor technology, wireless connectivity, and data analytics, which allow for the collection and interpretation of digital biomarkers outside of traditional clinical settings. The integration of wearable devices and remote monitoring solutions offers benefits such as increased patient engagement, improved disease management, and early detection of health changes, making it a prominent trend in the Digital Biomarkers market. As healthcare providers and patients embrace digital health solutions for personalized and proactive care, the demand for digital biomarkers derived from wearable devices is expected to continue to grow.

Digital Biomarkers Market Driver: Growing Emphasis on Precision Medicine and Personalized Healthcare

A key driver in the Digital Biomarkers market is the growing emphasis on precision medicine and personalized healthcare. Digital biomarkers, which encompass physiological, behavioral, and environmental indicators derived from digital health technologies, hold promise for improving disease diagnosis, treatment selection, and monitoring. By leveraging digital biomarkers, healthcare providers can gain deeper insights into individual health profiles, tailor interventions to specific patient needs, and optimize treatment outcomes. This driver is fueled by factors such as advances in genomics, big data analytics, and artificial intelligence, which enable the identification and validation of digital biomarkers for various diseases and health conditions. As healthcare systems shift towards personalized approaches to medicine, the demand for digital biomarkers as tools for precision diagnostics and treatment optimization is expected to drive market growth in the Digital Biomarkers segment.

Digital Biomarkers Market Opportunity: Development of Novel Digital Biomarker Algorithms and Platforms

An opportunity for growth in the Digital Biomarkers market lies in the development of novel digital biomarker algorithms and platforms. With the proliferation of digital health data generated from wearable devices, mobile apps, and remote monitoring systems, there is a need for sophisticated algorithms and platforms to analyze and interpret this data effectively. By investing in research and development efforts to develop advanced analytics algorithms, machine learning models, and integrated platforms for digital biomarker analysis, companies can enhance the accuracy, reliability, and clinical utility of digital biomarkers. Additionally, offering user-friendly interfaces, seamless integration with electronic health records, and interoperability with existing healthcare systems can further facilitate adoption and utilization of digital biomarkers by healthcare providers and patients. Embracing innovation in digital biomarker technology presents a compelling opportunity for market differentiation and leadership in the Digital Biomarkers market, offering solutions that drive personalized healthcare and improve patient outcomes.

 

Digital Biomarkers Market Segmentation

By Type

Wearable

Mobile based Applications

Sensors

Others

By Clinical Practice

Diagnostic Digital Biomarkers

Monitoring Digital Biomarkers

Predictive and Prognostic Digital Biomarkers

Others

By Therapeutic Area

Cardiovascular and metabolic disorders (CVMD)

Respiratory disorders

Psychiatric disorders

Sleep & Movement Disease

Neurological disorders

Musculoskeletal disorders

Others

By End-user

Healthcare companies

Healthcare Providers

Payers

Others

 

Geographical Analysis

North America (United States, Canada, Mexico)

Europe (Germany, France, United Kingdom, Spain, Italy, Rest of Europe)

Asia Pacific (China, India, Japan, South Korea, Rest of Asia Pacific)

South America (Brazil, Argentina, Rest of South America)

Middle East and Africa (Saudi Arabia, UAE, Rest of Middle East, South Africa, Egypt, Rest of Africa)

 

 

Digital Biomarkers Market Companies

ActiGraph LLC

Adherium Ltd

AliveCor Inc

Altoida Inc

Amgen Inc

Aural Analytic

Biogen Inc

Brainomix

Clario

Empatica Inc

Feel Therapeutics

Huma

Imagene AI

IXICO plc

Kinsa Inc

Koneksa

Neurotrack Technologies Inc

ResApp (Pfizer)

Sonde Health Inc

Vivo Sense

 

Reasons to Buy the Digital Biomarkers Market Study

• Deepen your industry insights and navigate uncertainties for strategy formulation, CAPEX, and Operational decisions

• Gain access to detailed insights on the Digital Biomarkers Market, encompassing current market size, growth trends, and forecasts till 2030.

• Access detailed competitor analysis, enabling competitive advantage through a thorough understanding of market players, strategies, and potential differentiation opportunities

• Stay ahead of the curve with insights on technological advancements, innovations, and upcoming trends

• Identify lucrative investment avenues and expansion opportunities within the Digital Biomarkers Market industry, guided by robust, data-backed analysis.

• Understand regional and global markets through country-wise analysis, regional market potential, regulatory nuances, and dynamics

• Execute strategies with confidence and speed through information, analytics, and insights on the industry value chain

• Corporate leaders, strategists, financial experts, shareholders, asset managers, and governmental representatives can make long-term planning scenarios and build an integrated and timely understanding of market dynamics

• Benefit from tailored solutions and expert consultation based on report insights, providing personalized strategies aligned with specific business needs.

TABLE OF CONTENTS

 

1 Introduction to 2024 Digital Biomarkers Market

1.1 Market Overview

1.2 Quick Facts

1.3 Scope/Objective of the Study

1.4 Market Definition

1.5 Countries and Regions Analyzed

1.6 Units, Currency, and Conversions

1.7 Industry Value Chain

 

2 Research Methodology

2.1 Market Size Estimation

2.2 Sources and Research Methodology

2.3 Data Triangulation

2.4 Assumptions and Limitations

 

3 Executive Summary

3.1 Global Digital Biomarkers Market Size Outlook, $ Million, 2021 to 2030

3.2 Digital Biomarkers Market Outlook By Type, $ Million, 2021 to 2030

3.3 Digital Biomarkers Market Outlook By Product, $ Million, 2021 to 2030

3.4 Digital Biomarkers Market Outlook By Application, $ Million, 2021 to 2030

3.5 Digital Biomarkers Market Outlook by Key Countries, $ Million, 2021 to 2030

 

4 Market Dynamics

4.1 Key Driving Forces of Digital Biomarkers Market Industry

4.2 Key Market Trends in Digital Biomarkers Market Industry

4.3 Potential Opportunities in Digital Biomarkers Market Industry

4.4 Key Challenges in Digital Biomarkers Market Industry

 

5 Market Factor Analysis

5.1 Competitive Landscape

5.1.1 Global Digital Biomarkers Market Share by Company (%), 2023

5.1.2 Product Offerings by Company

5.2 Porter’s Five Forces Analysis

 

6 Growth Outlook Across Scenarios

6.1 Growth Analysis-Case Scenario Definitions

6.2 Low Growth Scenario Forecasts

6.3 Reference Growth Scenario Forecasts

6.4 High Growth Scenario Forecasts

 

7 Global Digital Biomarkers Market Outlook By Segments

7.1 Digital Biomarkers Market Outlook by Segments

By Type

Wearable

Mobile based Applications

Sensors

Others

By Clinical Practice

Diagnostic Digital Biomarkers

Monitoring Digital Biomarkers

Predictive and Prognostic Digital Biomarkers

Others

By Therapeutic Area

Cardiovascular and metabolic disorders (CVMD)

Respiratory disorders

Psychiatric disorders

Sleep & Movement Disease

Neurological disorders

Musculoskeletal disorders

Others

By End-user

Healthcare companies

Healthcare Providers

Payers

Others

 

8 North America Digital Biomarkers Market Analysis And Outlook To 2030

8.1 Introduction to North America Digital Biomarkers Markets in 2024

8.2 North America Digital Biomarkers Market Size Outlook by Country, 2021-2030

8.2.1 United States

8.2.2 Canada

8.2.3 Mexico

8.3 North America Digital Biomarkers Market size Outlook by Segments, 2021-2030

By Type

Wearable

Mobile based Applications

Sensors

Others

By Clinical Practice

Diagnostic Digital Biomarkers

Monitoring Digital Biomarkers

Predictive and Prognostic Digital Biomarkers

Others

By Therapeutic Area

Cardiovascular and metabolic disorders (CVMD)

Respiratory disorders

Psychiatric disorders

Sleep & Movement Disease

Neurological disorders

Musculoskeletal disorders

Others

By End-user

Healthcare companies

Healthcare Providers

Payers

Others

 

9 Europe Digital Biomarkers Market Analysis And Outlook To 2030

9.1 Introduction to Europe Digital Biomarkers Markets in 2024

9.2 Europe Digital Biomarkers Market Size Outlook by Country, 2021-2030

9.2.1 Germany

9.2.2 France

9.2.3 Spain

9.2.4 United Kingdom

9.2.4 Italy

9.2.5 Russia

9.2.6 Norway

9.2.7 Rest of Europe

9.3 Europe Digital Biomarkers Market Size Outlook By Segments, 2021-2030

By Type

Wearable

Mobile based Applications

Sensors

Others

By Clinical Practice

Diagnostic Digital Biomarkers

Monitoring Digital Biomarkers

Predictive and Prognostic Digital Biomarkers

Others

By Therapeutic Area

Cardiovascular and metabolic disorders (CVMD)

Respiratory disorders

Psychiatric disorders

Sleep & Movement Disease

Neurological disorders

Musculoskeletal disorders

Others

By End-user

Healthcare companies

Healthcare Providers

Payers

Others

 

10 Asia Pacific Digital Biomarkers Market Analysis And Outlook To 2030

10.1 Introduction to Asia Pacific Digital Biomarkers Markets in 2024

10.2 Asia Pacific Digital Biomarkers Market Size Outlook by Country, 2021-2030

10.2.1 China

10.2.2 India

10.2.3 Japan

10.2.4 South Korea

10.2.5 Indonesia

10.2.6 Malaysia

10.2.7 Australia

10.2.8 Rest of Asia Pacific

10.3 Asia Pacific Digital Biomarkers Market size Outlook by Segments, 2021-2030

By Type

Wearable

Mobile based Applications

Sensors

Others

By Clinical Practice

Diagnostic Digital Biomarkers

Monitoring Digital Biomarkers

Predictive and Prognostic Digital Biomarkers

Others

By Therapeutic Area

Cardiovascular and metabolic disorders (CVMD)

Respiratory disorders

Psychiatric disorders

Sleep & Movement Disease

Neurological disorders

Musculoskeletal disorders

Others

By End-user

Healthcare companies

Healthcare Providers

Payers

Others

 

11 South America Digital Biomarkers Market Analysis And Outlook To 2030

11.1 Introduction to South America Digital Biomarkers Markets in 2024

11.2 South America Digital Biomarkers Market Size Outlook by Country, 2021-2030

11.2.1 Brazil

11.2.2 Argentina

11.2.3 Rest of South America

11.3 South America Digital Biomarkers Market size Outlook by Segments, 2021-2030

By Type

Wearable

Mobile based Applications

Sensors

Others

By Clinical Practice

Diagnostic Digital Biomarkers

Monitoring Digital Biomarkers

Predictive and Prognostic Digital Biomarkers

Others

By Therapeutic Area

Cardiovascular and metabolic disorders (CVMD)

Respiratory disorders

Psychiatric disorders

Sleep & Movement Disease

Neurological disorders

Musculoskeletal disorders

Others

By End-user

Healthcare companies

Healthcare Providers

Payers

Others

 

12 Middle East And Africa Digital Biomarkers Market Analysis And Outlook To 2030

12.1 Introduction to Middle East and Africa Digital Biomarkers Markets in 2024

12.2 Middle East and Africa Digital Biomarkers Market Size Outlook by Country, 2021-2030

12.2.1 Saudi Arabia

12.2.2 UAE

12.2.3 Oman

12.2.4 Rest of Middle East

12.2.5 Egypt

12.2.6 Nigeria

12.2.7 South Africa

12.2.8 Rest of Africa

12.3 Middle East and Africa Digital Biomarkers Market size Outlook by Segments, 2021-2030

By Type

Wearable

Mobile based Applications

Sensors

Others

By Clinical Practice

Diagnostic Digital Biomarkers

Monitoring Digital Biomarkers

Predictive and Prognostic Digital Biomarkers

Others

By Therapeutic Area

Cardiovascular and metabolic disorders (CVMD)

Respiratory disorders

Psychiatric disorders

Sleep & Movement Disease

Neurological disorders

Musculoskeletal disorders

Others

By End-user

Healthcare companies

Healthcare Providers

Payers

Others

 

13 Company Profiles

13.1  Company Snapshot

13.2 SWOT Profiles

13.3 Products and Services

13.4 Recent Developments

13.5 Financial Profile

List of Companies

ActiGraph LLC

Adherium Ltd

AliveCor Inc

Altoida Inc

Amgen Inc

Aural Analytic

Biogen Inc

Brainomix

Clario

Empatica Inc

Feel Therapeutics

Huma

Imagene AI

IXICO plc

Kinsa Inc

Koneksa

Neurotrack Technologies Inc

ResApp (Pfizer)

Sonde Health Inc

Vivo Sense

 

14 Appendix

14.1 Customization Offerings

14.2 Subscription Services

14.3 Related Reports

14.4 Publisher Expertise

Digital Biomarkers Market Segmentation

By Type

Wearable

Mobile based Applications

Sensors

Others

By Clinical Practice

Diagnostic Digital Biomarkers

Monitoring Digital Biomarkers

Predictive and Prognostic Digital Biomarkers

Others

By Therapeutic Area

Cardiovascular and metabolic disorders (CVMD)

Respiratory disorders

Psychiatric disorders

Sleep & Movement Disease

Neurological disorders

Musculoskeletal disorders

Others

By End-user

Healthcare companies

Healthcare Providers

Payers

Others

 

Geographical Analysis

North America (United States, Canada, Mexico)

Europe (Germany, France, United Kingdom, Spain, Italy, Rest of Europe)

Asia Pacific (China, India, Japan, South Korea, Rest of Asia Pacific)

South America (Brazil, Argentina, Rest of South America)

Middle East and Africa (Saudi Arabia, UAE, Rest of Middle East, South Africa, Egypt, Rest of Africa)